← Portfolio Scout

Portfolio company

Modulight Biotherapeutics

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

5 investors

Sectors

Deep TechDigital Health

About

The company develops optogenetic neuromodulation therapies using light-sensitive proteins to treat patients with severe neurological disorders, including chronic pain, epilepsy and movement disorders.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies